India's drug regulator forms AI expert committee
India's drug regulator has set up an AI expert committee; clinical trial decisions continue to rest on the existing scientific and technical assessment. The news is dated 21 September.
Who is affected and how
- pharmaceuticals
- In Indian clinical trial decisions, expert committee review still counts and AI does not replace it.
Sources
- India’s Drug Regulator Forms AI Expert Committee: What We Knowmedianama.com · Sep 21, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.